Nuhey News

We talk about the MARKET

Global Transmucosal Drug Delivery Systems Market Revenue Estimates and Forecasts (2018-2028)

The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.

Fully considering the economic change by this health crisis, Oral Drug Delivery accounting for % of the Transmucosal Drug Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Transmucosal Drug Delivery Systems market size is valued at US$ million in 2021, while the North America and Europe Transmucosal Drug Delivery Systems are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Transmucosal Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Oral Drug Delivery
  • Nasal Drug Delivery
  • Rectal Drug Delivery
  • Other

Segment by Application

  • Hospitals
  • Clinics
  • Others

By Company

  • 3M
  • Antares Pharma
  • Aveva Drug Delivery Systems
  • Corium International
  • Acrux Limited
  • ALZA Corporation
  • DURECT Corporation
  • Generex Biotechnology

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479